BRPI1013288A2 - uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto - Google Patents
uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o compostoInfo
- Publication number
- BRPI1013288A2 BRPI1013288A2 BRPI1013288A BRPI1013288A BRPI1013288A2 BR PI1013288 A2 BRPI1013288 A2 BR PI1013288A2 BR PI1013288 A BRPI1013288 A BR PI1013288A BR PI1013288 A BRPI1013288 A BR PI1013288A BR PI1013288 A2 BRPI1013288 A2 BR PI1013288A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- kit
- diseases
- involved
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 230000002159 abnormal effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000005176 gastrointestinal motility Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009163182 | 2009-07-09 | ||
| JP2009188464 | 2009-08-17 | ||
| PCT/JP2010/061660 WO2011004882A1 (ja) | 2009-07-09 | 2010-07-09 | 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1013288A2 true BRPI1013288A2 (pt) | 2016-03-29 |
Family
ID=43429307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013288A BRPI1013288A2 (pt) | 2009-07-09 | 2010-07-09 | uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8648080B2 (pt) |
| EP (1) | EP2452680B1 (pt) |
| JP (4) | JP5802898B2 (pt) |
| KR (1) | KR101605063B1 (pt) |
| CN (2) | CN105919998B (pt) |
| BR (1) | BRPI1013288A2 (pt) |
| CA (1) | CA2765529C (pt) |
| ES (1) | ES2767251T3 (pt) |
| HK (1) | HK1225608A1 (pt) |
| MX (1) | MX2012000275A (pt) |
| RU (1) | RU2586276C2 (pt) |
| WO (1) | WO2011004882A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3071206B1 (en) | 2013-11-22 | 2021-02-17 | CL Biosciences LLC | Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis |
| CN105708812A (zh) * | 2014-12-02 | 2016-06-29 | 江苏柯菲平医药股份有限公司 | 一种5-（2-氟苯基）-n-甲基-1-（3-吡啶基磺酰基）-1h-吡咯-3-甲氨冻干粉针及其制备方法 |
| KR101684053B1 (ko) * | 2015-01-20 | 2016-12-08 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 신규 결정형 및 이의 제조방법 |
| MA41850A (fr) | 2015-03-31 | 2018-02-06 | Takeda Pharmaceuticals Co | Nouvelles utilisations pharmaceutiques |
| US10512635B2 (en) | 2015-06-08 | 2019-12-24 | Cj Healthcare Corporation | Uses of benzimidazole derivative for nocturnal acid breakthrough |
| CN105078891B (zh) * | 2015-08-20 | 2018-04-24 | 寿光富康制药有限公司 | 一种tak-438脂质体及其制备方法和应用 |
| CN105168131B (zh) * | 2015-09-17 | 2018-04-24 | 寿光富康制药有限公司 | 一种tak-438纳米乳的制备方法 |
| CN106913859B (zh) * | 2015-12-25 | 2021-05-11 | 中美华世通生物医药科技(武汉)股份有限公司 | 药物组合物及制备方法 |
| CN105663096B (zh) * | 2016-01-25 | 2019-06-14 | 南京济群医药科技股份有限公司 | 一种沃诺拉赞口腔速溶膜剂及其制备方法 |
| KR101829706B1 (ko) | 2016-09-21 | 2018-02-19 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 산부가염 |
| JOP20190060A1 (ar) * | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
| CN112933091B (zh) * | 2020-09-07 | 2023-01-06 | 天地恒一制药股份有限公司 | 一种抗胃酸类疾病的药物组合物及应用 |
| UY39479A (es) * | 2020-10-23 | 2021-11-30 | Hk Inno N Corp | Comprimido de desintegración oral que comprende compuesto derivado de benzimidazol y procedimiento de preparación del mismo |
| WO2023106841A1 (ko) * | 2021-12-08 | 2023-06-15 | (주) 팜젠사이언스 | 벤즈이미다졸 유도체 화합물 및 이의 용도 |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5996272A (ja) | 1982-11-26 | 1984-06-02 | Isuzu Motors Ltd | 金属表面の強化層形成方法 |
| TW282460B (pt) | 1993-12-28 | 1996-08-01 | Yamanouchi Pharma Co Ltd | |
| WO1996005177A1 (en) * | 1994-08-13 | 1996-02-22 | Yuhan Corporation | Novel pyrimidine derivatives and processes for the preparation thereof |
| SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| SE9802794D0 (sv) | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
| SE9802793D0 (sv) | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
| RS50145B (sr) * | 1998-09-23 | 2009-03-25 | Altana Pharma Ag., | Tetrahidropiridoetri |
| DE69938192D1 (en) | 1998-11-03 | 2008-04-03 | Nycomed Gmbh | Imidazonaphthyridine |
| KR100272471B1 (ko) | 1998-11-17 | 2000-11-15 | 김선진 | 신규의 피리미딘 유도체 및 그의 제조방법 |
| TWI287014B (en) | 1999-06-15 | 2007-09-21 | Sankyo Co | Optically active pyrrolopyridazine compound |
| MXPA02009551A (es) | 2000-03-29 | 2004-05-14 | Altana Pharma Ag | Profarmacos de derivados de imidazopiridina. |
| WO2002030920A1 (fr) | 2000-10-12 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Composes derives de benzimidazole, leur procede de production et leur utilisation |
| WO2003014123A1 (en) | 2001-08-10 | 2003-02-20 | Altana Pharma Ag | Tricyclic imidazopyridines |
| SE0102808D0 (sv) | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | New compounds |
| KR20050086584A (ko) | 2002-11-19 | 2005-08-30 | 알타나 파마 아게 | 8-치환 이미다조피리딘 |
| AR043063A1 (es) | 2002-12-13 | 2005-07-13 | Altana Pharma Ag | Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas |
| MXPA05010310A (es) | 2003-04-04 | 2005-11-17 | Altana Pharma Ag | Bencimidazoles ciclicos. |
| AU2004243444A1 (en) | 2003-05-27 | 2004-12-09 | Altana Pharma Ag | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| SE0301905D0 (sv) | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | Novel imidazopyridine compound I with therapeutic effect |
| EP1663313A2 (en) | 2003-08-29 | 2006-06-07 | Dynogen Pharmaceuticals Inc. | Compositions useful for treating gastrointestinal motility disorders |
| WO2005026164A1 (en) | 2003-09-18 | 2005-03-24 | Altana Pharma Ag | Pharmacologically active imidazo[4,5-c]pyridines |
| AR046893A1 (es) | 2003-12-16 | 2005-12-28 | Altana Pharma Ag | Bencimidazoles triciclicos |
| AR046941A1 (es) | 2003-12-19 | 2006-01-04 | Altana Pharma Ag | Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico |
| WO2005070927A2 (en) | 2004-01-26 | 2005-08-04 | Altana Pharma Ag | 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors |
| AU2005212856A1 (en) | 2004-02-18 | 2005-08-25 | Altana Pharma Ag | 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
| EP1735318A2 (en) | 2004-03-17 | 2006-12-27 | Altana Pharma AG | 7h-8,9-dihydro-pyrano(2,3-c)imidazo(1,2a)pyridine derivatives and their use as gastric acid secretion inhibitors |
| AR048869A1 (es) | 2004-04-26 | 2006-06-07 | Altana Pharma Ag | Bencimidazoles triciclicos |
| DE602005002751T2 (de) | 2004-06-09 | 2008-07-17 | Nycomed Gmbh | Substituierte tricyclische benzimidazole |
| KR100958830B1 (ko) | 2004-09-03 | 2010-05-24 | 주식회사유한양행 | 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법 |
| KR100946219B1 (ko) | 2004-09-03 | 2010-03-08 | 주식회사유한양행 | 피롤로[3,2-ｃ]피리딘 유도체 및 그의 제조방법 |
| DK1805177T3 (da) | 2004-09-03 | 2010-08-02 | Yuhan Corp | Pyrrolo(3,2-C]pyridinderivater og fremgangsmåde til fremstilling deraf |
| AU2005291284A1 (en) | 2004-10-01 | 2006-04-13 | Altana Pharma Ag | Substituted tricyclic benzimidazoles |
| AR051041A1 (es) | 2004-10-04 | 2006-12-13 | Altana Pharma Ag | Bencimidazoles triciclicos condensados |
| AR051375A1 (es) | 2004-10-15 | 2007-01-10 | Altana Pharma Ag | Imidazopiridinas difluoro substituidas |
| US20080119510A1 (en) | 2004-12-09 | 2008-05-22 | Altana Pharma Ag | Substituted Imidazo [4,5-B] Pyridines As Inhibitors Of Gastric Acid Secretion |
| KR101137168B1 (ko) | 2005-03-09 | 2012-04-19 | 주식회사유한양행 | 피롤로［２,３-ｄ］피리다진 유도체 및 그의 제조방법 |
| KR101122376B1 (ko) | 2005-03-09 | 2012-03-26 | 주식회사유한양행 | 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법 |
| US20080255358A1 (en) | 2005-03-24 | 2008-10-16 | Mark James Bamford | Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases |
| JP2008534476A (ja) | 2005-03-24 | 2008-08-28 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 胃腸疾病の治療のために有用なチオアミド置換された三環式のベンゾイミダゾール |
| EP1910313A1 (en) | 2005-03-24 | 2008-04-16 | Nycomed GmbH | 6-thioamide substituted benzimidazoles |
| EP1877410A1 (en) | 2005-04-29 | 2008-01-16 | Nycomed GmbH | Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity |
| AR057061A1 (es) | 2005-06-16 | 2007-11-14 | Altana Pharma Ag | Espiro-bencimidazoles farmaceuticamente activos y su uso en la fabricacion de medicamentos |
| TW200726752A (en) | 2005-06-22 | 2007-07-16 | Altana Pharma Ag | Process for the production of intermediates for the preparation of tricyclic benzimidazoles |
| GB0513423D0 (en) | 2005-06-30 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
| JP2009504798A (ja) | 2005-08-22 | 2009-02-05 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 同位体置換されたベンゾイミダゾール誘導体 |
| BRPI0615111B8 (pt) * | 2005-08-30 | 2021-05-25 | Takeda Pharmaceuticals Co | composto, composição farmacêutica, e, uso do composto |
| US7776873B2 (en) | 2005-12-01 | 2010-08-17 | Yuhan Corporation | Method for treating damage to gastric mucosa |
| ATE471319T1 (de) | 2005-12-19 | 2010-07-15 | Raqualia Pharma Inc | Chromansubstituierte benzimidazole und ihre verwendung als säurepumpenhemmer |
| CA2647862A1 (en) | 2006-03-31 | 2007-10-11 | Takeda Pharmaceutical Company Limited | Acid secretion inhibitor |
| WO2008015196A1 (en) | 2006-07-31 | 2008-02-07 | Nycomed Gmbh | 5-,7-bis-substituted imidazo[1,2-a]pyridines |
| KR101109866B1 (ko) | 2006-09-21 | 2012-04-12 | 라퀄리아 파마 인코포레이티드 | 선택성 산 펌프 억제제로서의 벤즈이미다졸 유도체 |
| WO2008058990A1 (en) | 2006-11-16 | 2008-05-22 | Nycomed Gmbh | 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors |
| WO2008071766A2 (en) | 2006-12-14 | 2008-06-19 | Nycomed Gmbh | Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion |
| WO2008071765A1 (en) | 2006-12-14 | 2008-06-19 | Nycomed Gmbh | Pharmaceutically active spiro-substituted benzimidazole derivatives |
| WO2008084067A2 (en) | 2007-01-12 | 2008-07-17 | Nycomed Gmbh | Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives |
| WO2008095912A2 (en) | 2007-02-06 | 2008-08-14 | Nycomed Gmbh | Enantiopure pharmacologically active tricyclic benzimidazoles |
| US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| WO2008151927A2 (en) | 2007-06-15 | 2008-12-18 | Nycomed Gmbh | 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| TW200920366A (en) | 2007-09-28 | 2009-05-16 | Takeda Pharmaceutical | 5-membered heterocyclic compound |
| WO2009041447A1 (ja) | 2007-09-28 | 2009-04-02 | Takeda Pharmaceutical Company Limited | ５員複素環化合物 |
-
2010
- 2010-07-09 WO PCT/JP2010/061660 patent/WO2011004882A1/ja active Application Filing
- 2010-07-09 EP EP10797193.9A patent/EP2452680B1/en active Active
- 2010-07-09 US US13/383,056 patent/US8648080B2/en active Active
- 2010-07-09 MX MX2012000275A patent/MX2012000275A/es active IP Right Grant
- 2010-07-09 CA CA2765529A patent/CA2765529C/en active Active
- 2010-07-09 CN CN201610246787.9A patent/CN105919998B/zh active Active
- 2010-07-09 BR BRPI1013288A patent/BRPI1013288A2/pt not_active Application Discontinuation
- 2010-07-09 KR KR1020127002781A patent/KR101605063B1/ko active Active
- 2010-07-09 CN CN2010800308648A patent/CN102470126A/zh active Pending
- 2010-07-09 JP JP2011521969A patent/JP5802898B2/ja active Active
- 2010-07-09 RU RU2012104533/15A patent/RU2586276C2/ru active
- 2010-07-09 ES ES10797193T patent/ES2767251T3/es active Active
-
2013
- 2013-04-30 JP JP2013094888A patent/JP5699309B2/ja active Active
-
2014
- 2014-10-24 JP JP2014217434A patent/JP5978447B2/ja active Active
-
2016
- 2016-06-23 JP JP2016125015A patent/JP6212765B2/ja active Active
- 2016-12-05 HK HK16113855.9A patent/HK1225608A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2765529C (en) | 2017-02-07 |
| JP5802898B2 (ja) | 2015-11-04 |
| JP2016166255A (ja) | 2016-09-15 |
| JP5699309B2 (ja) | 2015-04-08 |
| JP6212765B2 (ja) | 2017-10-18 |
| US20120115820A1 (en) | 2012-05-10 |
| RU2586276C2 (ru) | 2016-06-10 |
| WO2011004882A1 (ja) | 2011-01-13 |
| KR101605063B1 (ko) | 2016-03-21 |
| CN105919998A (zh) | 2016-09-07 |
| EP2452680A1 (en) | 2012-05-16 |
| JP5978447B2 (ja) | 2016-08-24 |
| RU2012104533A (ru) | 2013-08-20 |
| JP2013144719A (ja) | 2013-07-25 |
| MX2012000275A (es) | 2012-02-08 |
| KR20120052269A (ko) | 2012-05-23 |
| CA2765529A1 (en) | 2011-01-13 |
| US8648080B2 (en) | 2014-02-11 |
| CN105919998B (zh) | 2021-08-24 |
| JP2015038140A (ja) | 2015-02-26 |
| EP2452680A4 (en) | 2013-12-04 |
| CN102470126A (zh) | 2012-05-23 |
| EP2452680B1 (en) | 2019-12-18 |
| HK1225608A1 (zh) | 2017-09-15 |
| ES2767251T3 (es) | 2020-06-17 |
| JPWO2011004882A1 (ja) | 2012-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1013288A2 (pt) | uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto | |
| BRPI0911685A2 (pt) | composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit | |
| BR112014029674A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença, utilização de um composto, conjunto para o tratamento de uma condição mediada pela quinase pim e invenção | |
| BRPI1008383A2 (pt) | composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto | |
| BRPI1005153A2 (pt) | composto, composição farmacêutica, uso de um composto, metodo para tratar um indivíduo que sofre de uma condição patológica ou doença e produto de combinação | |
| HUE040307T2 (hu) | Új oxintomodulin-származékok és azokat tartalmazó gyógyszerészeti készítmények elhízás kezelésére | |
| BR112012016398A2 (pt) | Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa | |
| BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
| PT2367561E (pt) | Composições e métodos para o tratamento da doença celíaca | |
| BRPI0906547A2 (pt) | composição refrigerante e kit para uma composição refrigerante | |
| BRPI0911923A2 (pt) | dispositivos filamentosos para o tratamento de defeitos vasculares | |
| BRPI0815387A2 (pt) | composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição | |
| BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
| PL2512515T3 (pl) | Kompozycja farmaceutyczna do leczenia zespołu suchego oka | |
| BRPI1013984A2 (pt) | composto , composição farmacêutica, método para tratamento ou profilaxia de uma doença ou condição, e, uso de um composto. | |
| BR112014009932A2 (pt) | derivados de hidroxamato para inibidores da hdac e composição farmacêutica contendo os mesmos | |
| BRPI1005169A2 (pt) | combinação de (a) metotrexato e (b) um inibidor de dhodh não-hepatotóxico, uso de uma combinação, produto, conjunto, embalagem e método de tratamento | |
| BR112012029227A2 (pt) | processo para a preparação de um conjunto quiral, composto quiral, composição, composição farmacêutica, uso de uma composição, método de tratamento ou prevenção e uso de um composto | |
| BRPI0910623A2 (pt) | adaptador para uma garrafa de água de um endoscópio | |
| BR112012002578A2 (pt) | composição para o tratamento da fibrose cística | |
| BRPI1008598A2 (pt) | composição farmacêutica para inalação | |
| BRPI0922619A2 (pt) | compostos de plasmalogen, composições farmacêuticas contendo os mesmos e métodos para tratar doenças do envelhecimento | |
| BRPI0915439A2 (pt) | composição tópica para o tratamento de ceratose actínica | |
| BRPI0911580A2 (pt) | composições para o tratamento de uma condição artrítica | |
| BRPI1009781A2 (pt) | compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal: appeal against refusal |